Health Condition 1: 4- Measurement and Monitoring
Conditions
Interventions
Intervention1: Noradrenaline: The infusion of drugs IV noradrenaline start at 0.2microgm/kg/min ,If shock did not reverse in 15mins we increase infusion rate of noradrenaline 0.3microgm.kg/min .If sh
Sponsors
Kalinga institute of medical sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. All NICU admitted neonates with clinical diagnosis of sepis and shock
Exclusion criteria
Exclusion criteria: 1. Neonates with congenital heart diseases 2. Neonates with hypoxic ishaemic encephalopathy 3. Congenital malformation 4. Neonates with surgical intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of norepinephrine and dopamine as the initial vasopressor in neonatal shockTimepoint: 45mins | — |
Secondary
| Measure | Time frame |
|---|---|
| Reversal of shock during first 45mins of vaso active drug infusion characterised by MBP above 5th centile,CRT3sec,falling heart rate more than 10Timepoint: 45mins | — |
Countries
India
Contacts
Public ContactDr Manas Kumar Nayak
Kalinga Institute of Medical Sciences
Outcome results
None listed